NASDAQ: ETON - Eton Pharmaceuticals, Inc.

六个月盈利: +241.3%
股息率: 0.00%
部门: Healthcare

促销时间表 Eton Pharmaceuticals, Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司 Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and dehydrated alcohol injection to treat methanol poisoning.

更多详情
It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis; Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis; EPRONTIA, a liquid formulation of topiramate; ZONISADE, a liquid formulation of zonisamide for the treatment of partial seizures in patients with epilepsy; and Lamotrigine for Oral Suspension for the treatment of epilepsy. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

IPO date 2018-11-13
ISIN US29772L1089
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.etonpharma.com
Цена ао 15.06
每日价格变化: +1.62% (15.45)
每周价格变化: +8.2% (14.51)
每月价格变化: -8.03% (17.07)
3个月内价格变化: +16.04% (13.53)
六个月内的价格变化: +241.3% (4.6)
每年价格变化: +252.02% (4.46)
3年内价格变化: +331.32% (3.64)
5年内价格变化: +135.74% (6.66)
10年价格变化: 0% (15.7)
年初以来价格变化: +20.31% (13.05)
所有参数

低估

姓名 意义 年级
P/S 3.78 4
P/BV 7.72 1
P/E 0 0
EV/EBITDA -355.93 0
全部的: 3.63

效率

姓名 意义 年级
ROA, % -2.95 0
ROE, % -6.05 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -18.75 10
全部的: 6

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 3199.48 10
盈利能力 Ebitda, % -98.4 0
盈利能力 EPS, % -96.42 0
全部的: 2
更多详情

机构 体积 分享, %
Opaleye Management Inc. 2529887 9.85
Vanguard Group Inc 1027688 4
Westside Investment Management, Inc. 563110 2.19
Acuitas Investments LLC 492054 1.92
Paradigm Capital Management 300000 1.17
Blackrock Inc. 284241 1.11
Bridgeway Capital Management, Inc. 253362 0.99
Geode Capital Management, LLC 227256 0.88
Parkman Healthcare Partners LLC 199168 0.78
Ameriprise Financial, Inc. 161928 0.63

ETF 分享, % 本年盈利能力, % 股息, %
iShares Micro-Cap ETF 0.027 17.09 1.54048



导师 职称 支付 出生年份
Mr. Sean E. Brynjelsen President, CEO & Director 939.42k 1972 (53 年)
Mr. James R. Gruber CPA CFO, Treasurer & Secretary 554.44k 1972 (53 年)
Mr. David C. Krempa Chief Business Officer 547.86k 1989 (36 年)
Mr. Kevin Guthrie Executive VP of Commercial Operations N/A
Danka Radosavljevic Senior Vice President of Quality & Operations
Mr. Scott Grossenbach Vice President of Sales Operations

地址: United States, Deer Park. IL -, 21925 W. Field Parkway - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.etonpharma.com